BioCentury
ARTICLE | Company News

CureVac infectious news

March 17, 2014 7:00 AM UTC

The European Commission awarded CureVac a €2 million ($2.8 million) innovation inducement prize to develop its RNActive vaccine technology. In April 2012, the EC opened the call for proposals for solu...